Publikationer 2018

Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF.

Savarese G, Orsini N, Hage C, Vedin O, Cosentino F, Rosano GMC, Dahlström U, Lund LH.

JACC Heart Fail 2018 Mars;6(3):246-256


Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.

Savarese G, Sartipy U, Friberg L, Dahlström U, Lund LH

Heart. 2018 Jul;104(13):1093-1100.


Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.

Teng TK, Tay WT, Dahlström U, Benson L, Lam CSP, Lund LH

Int J Cardiol. 2018 Mar 1;254:203-209


Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics.

B. Eriksson, P. Wändell, U. Dahlström, P. Näsman, L. H. Lund & M. Edner 

Scandinavian Journal of Primary Health Care, 36:2, 207-215